ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

Guideline Revisions or Outstanding Investigator Grant Still Controversial

December 9, 1983

MD Anderson Faculty Slam Leadership, Question Moon Shots, Bemoan Workload

March 29, 2013

William Nelson Named Cancer Center Director At Johns Hopkins.

November 7, 2008

PhRMA Offers Assistance For Part D “Doughnut Hole”

June 26, 2009

Specialists List 15 Criteria For Choosing Health Insurance.

January 14, 2000

Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment

July 30, 2004